February « 2015 « Science and Enterprise

RNA Flu Therapy Clinical Trials Complete Enrollment

By Alan, on February 19th, 2015%

Influenza ultrastructure illustration (Dan Higgins, CDC)

19 February 2015. Two late-stage clinical trials testing an influenza treatment that disrupts a virus’s genetic replication ability finished recruiting more than 2,000 participants worldwide. The trials are being conducted by MediVector Inc., a drug development company in Boston, for Joint Project Manager Medical Countermeasure Systems, an . . . → Read More: RNA Flu Therapy Clinical Trials Complete Enrollment

Synthetic Bone Marrow System Produces Platelets

By Alan, on February 19th, 2015%

Alessandra Balduini (alessandrabalduini.com)

19 February 2015. Bioengineers in the U.S. and Italy designed a programmable bioreactor system that emulates bone marrow to produce platelets, blood cells that coagulate to prevent bleeding. The team led by Tufts University bioengineering professors Alessandra Balduini and David Kaplan published its findings last month in the journal Blood . . . → Read More: Synthetic Bone Marrow System Produces Platelets

European Patent Issued for Rare Liver Disease Drug

By Alan, on February 18th, 2015%

(National Library of Medicine, NIH)

18 February 2015. Synageva BioPharma Corp., a biopharmaceutical company developing therapies for rare diseases, received a European patent on its treatment for lysosomal acid lipase deficiency, an inherited disease causing severe disruptions and injuries to the liver. The European Patent Office issued patent number EP2613798 B1 on 11 February . . . → Read More: European Patent Issued for Rare Liver Disease Drug

Flu Vaccine Shown to Protect Against Avian Influenza

By Alan, on February 18th, 2015%

H7N9 virus (U.S. Centers for Disease Control and Prevention)

18 February 2015. Researchers at University of Chicago and Mount Sinai medical centers found people who receive the seasonal flu vaccine also generate antibodies that in lab cultures and animals act against avian (H7N9) and other influenza strains. The team led by Chicago’s Patrick Wilson . . . → Read More: Flu Vaccine Shown to Protect Against Avian Influenza

Redesigned Crutch Developer Gains $450K in Early Funds

By Alan, on February 17th, 2015%

Partha Unnava and the Better Walk crutch with President Obama at the White House Maker Faire in June 2014 (Better Walk Inc. and whitehouse.gov)

17 February 2015. A company developing a more comfortable alternative to standard underarm or forearm crutches, secured $450,000 in its first venture funding round. Financing for Better Walk Inc., . . . → Read More: Redesigned Crutch Developer Gains $450K in Early Funds

Patent Awarded for Neurostimulation Electronics

By Alan, on February 17th, 2015%

U.S. Patent and Trademark Office (A. Kotok)

17 February 2015. A U.S. patent on electronic components for switching and pulse generation in neurostimulation devices was awarded earlier this month. The Patent and Trademark Office awarded patent number 8,948,880 on 3 February to Barry Yomtov, founder and chief technologist of AdvaStim Inc. in Beverly, . . . → Read More: Patent Awarded for Neurostimulation Electronics

Image Analysis Company Raises $800K for New Venture

By Alan, on February 16th, 2015%

Omero includes an image viewer that allows for annotation (openmicroscopy.org)

16 February 2015. Glencoe Software Inc., a developer of image analysis and management software for research and pharmaceutical applications, raised $800,000 to fund a new venture in digital pathology. Financing for the Seattle company’s venture is provided by TIE Angels Group – Seattle and . . . → Read More: Image Analysis Company Raises $800K for New Venture

Thyroid Cancer Drug Approved by FDA

By Alan, on February 16th, 2015%

(thyca.org)

16 February 2015. The U.S. Food and Drug Administration approved on Friday a drug for differentiated thyroid cancers, where the cancer continues to grow despite treatments with radioactive iodine. The drug, lenvatinib, is marketed by Eisai Inc. in Woodcliffe, New Jersey, under the brand name Lenvima.

The thyroid gland helps the body . . . → Read More: Thyroid Cancer Drug Approved by FDA

Intrexon Acquires Biopharm Company for $60M

By Alan, on February 13th, 2015%

Lactococcus lactis bacteria (Joint Genome Institute)

13 February 2015. Intrexon Corp., a biotechnology company in Gaithersburg, Maryland specializing in synthetic biology, is acquiring ActoGeniX, developing biologic therapies from engineered microbes. Under the deal, stockholders of ActoGeniX, based in Ghent, Belgium, are receiving $30 million in cash plus another $30 million in Intrexon stock.

ActoGeniX . . . → Read More: Intrexon Acquires Biopharm Company for $60M

Devices Assembled to Record Doctor-Patient Interactions

By Alan, on February 13th, 2015%

Nadir Weibel (Univ of California, San Diego)

13 February 2015. Computer scientists at University of California in San Diego assembled a collection of audio and video devices into a portable package that records doctors’ consultations with patients when also using electronic health records. The team led by computer science researcher Nadir Weibel that . . . → Read More: Devices Assembled to Record Doctor-Patient Interactions

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise